Medicare Enrolled
Dr. Mark Diamond, MD
Neurology · Morristown, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Diamond from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Diamond?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Diamond
Dr. Mark Diamond is a neurology specialist in Morristown, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Diamond performed 35,995.1 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Diamond received a total of $101,111 from 103 pharmaceutical and/or device companies across 1272 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Diamond is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 1% volume in NJ
$101,111 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗35,995.1
Medicare services
Top 1% in NJ for neurology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
34,745.1 | $5 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
349 | $70 | $101 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
266 | $133 | $188 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $103 | $143 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
85 | $127 | $186 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $151 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
70 | $143 | $189 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 47 | $70 | $93 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
46 | $106 | $156 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
45 | $111 | $142 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
41 | $113 | $155 |
| New patient office visit, complex (60-74 min) | 33 | $165 | $245 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
26 | $102 | $130 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $65 | $91 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
17 | $169 | $231 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
11 | $356 | $454 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$101,111
Total received (2018-2024)
Avg $14,444/year across 7 years
Top 4% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
103
Companies
1,272
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,820
2023
$8,298
2022
$21,818
2021
$39,943
2020
$14,474
2019
$2,107
2018
$9,651
Payments by company (2024)
ABBVIE INC.
$3,104
PFIZER INC.
$337
Neurocrine Biosciences, Inc.
$159
Celgene Corporation
$158
E.R. Squibb & Sons, L.L.C.
$125
TG Therapeutics, Inc.
$119
Teva Pharmaceuticals USA, Inc.
$90
UCB, Inc.
$87
EMD Serono, Inc.
$81
Lilly USA, LLC
$81
Lundbeck LLC
$71
ARGENX US, INC.
$68
Eisai Inc.
$53
SK Life Science, Inc.
$48
Alexion Pharmaceuticals, Inc.
$38
Genentech USA, Inc.
$35
GE HEALTHCARE
$29
Aucta Pharmaceuticals, Inc.
$23
CSL Behring
$20
Vanda Pharmaceuticals Inc.
$18
AstraZeneca Pharmaceuticals LP
$18
Xeris Pharmaceuticals, Inc.
$15
Biogen, Inc.
$15
Sumitomo Pharma America, Inc.
$14
Azurity Pharmaceuticals, Inc.
$14
Top 3 companies account for 74.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$21,498
Biohaven Pharmaceuticals, Inc.
$20,719
Allergan, Inc.
$15,239
Biohaven Pharmaceutical Holding Company Ltd.
$14,289
ABBVIE INC.
$8,628
EMD Serono, Inc.
$7,729
Teva Pharmaceuticals USA, Inc.
$1,877
Novartis Pharmaceuticals Corporation
$713
PFIZER INC.
$602
Alexion Pharmaceuticals, Inc.
$570
UCB, Inc.
$564
Biogen, Inc.
$539
Allergan Inc.
$511
Supernus Pharmaceuticals, Inc.
$482
Amgen Inc.
$463
Sunovion Pharmaceuticals Inc.
$458
Celgene Corporation
$426
Lundbeck LLC
$395
Neurocrine Biosciences, Inc.
$359
Lilly USA, LLC
$249
W. L. Gore & Associates, Inc.
$247
CSL Behring
$229
E.R. Squibb & Sons, L.L.C.
$219
SK Life Science, Inc.
$189
Eisai Inc.
$185
Genentech USA, Inc.
$170
Acorda Therapeutics, Inc
$156
GE HEALTHCARE
$153
TG Therapeutics, Inc.
$119
ARBOR PHARMACEUTICALS, INC.
$115
Validus Pharmaceuticals LLC
$115
Amneal Pharmaceuticals LLC
$111
Boston Scientific Corporation
$109
ARGENX US, INC.
$101
Grifols USA, LLC
$97
Abbott Laboratories
$97
UPSHER-SMITH LABORATORIES LLC
$97
JAZZ PHARMACEUTICALS INC.
$83
Bausch Health US, LLC
$83
Kyowa Kirin, Inc.
$83
AstraZeneca Pharmaceuticals LP
$78
TG THERAPEUTICS, INC.
$78
Avanir Pharmaceuticals, Inc.
$73
ACADIA Pharmaceuticals Inc
$71
Janssen Pharmaceuticals, Inc
$68
Nevro Corp.
$63
GENZYME CORPORATION
$63
Takeda Pharmaceuticals U.S.A., Inc.
$61
Sumitomo Pharma America, Inc.
$58
Jazz Pharmaceuticals Inc.
$57
LivaNova USA, Inc.
$57
CATALYST PHARMACEUTICALS, INC.
$57
Scilex Pharmaceuticals Inc.
$47
Medtronic USA, Inc.
$47
Mallinckrodt Enterprises LLC
$45
Aprecia Pharmaceuticals, LLC
$45
Bayer HealthCare Pharmaceuticals Inc.
$44
Neurelis, Inc.
$43
Alnylam Pharmaceuticals Inc.
$41
Mallinckrodt LLC
$41
Merz North America, Inc.
$34
Avion Pharmaceuticals
$34
Life Molecular Imaging Ltd
$33
Vanda Pharmaceuticals Inc.
$31
ANI Pharmaceuticals, Inc.
$30
Almatica Pharma LLC
$30
Currax Pharmaceuticals LLC
$29
Adamas Pharmaceuticals, Inc.
$29
Strongbridge US INC.
$29
Banner Life Sciences, LLC
$28
Xeris Pharmaceuticals, Inc.
$28
EISAI INC.
$28
ASSERTIO THERAPEUTICS, Inc.
$28
BANNER LIFE SCIENCES, LLC
$28
Impax Laboratories, Inc.
$27
GE HealthCare
$27
Vertical Pharmaceuticals, LLC
$26
Assertio Therapeutics, Inc.
$26
Merz Pharmaceuticals, LLC
$25
Aucta Pharmaceuticals, Inc.
$23
BeiGene USA, Inc.
$21
Axsome Therapeutics, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$16
Exeltis, USA Inc.
$16
Piramal Imaging Limited
$16
Octapharma USA, Inc.
$15
IMPEL PHARMACEUTICALS INC.
$15
SCILEX PHARMACEUTICALS INC.
$15
Virtus Pharmaceuticals LLC
$14
Adlon Therapeutics L.P.
$14
Azurity Pharmaceuticals, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
Greenwich Biosciences, Inc.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Pernix Therapeutics Holdings, Inc.
$14
Egalet US Inc
$14
Mylan Specialty L.P.
$13
US WorldMeds, LLC
$13
Alfasigma USA, Inc.
$13
Sobi, Inc
$12
Akcea Therapeutics, Inc.
$12
AQUESTIVE THERAPEUTICS, INC.
$12
Harmony Biosciences LLC
$12
Top 3 companies account for 56.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADHANSIA XR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · BRUKINSA · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · Cambia · Corlanor · DIVIGEL · DUOPA · Dhivy · ELIQUIS · ELYXYB - celecoxib · EMGALITY · ERBITUX · Enspryng · Epidiolex · Equetro · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GLATIRAMER ACETATE · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · General - DBS · Gralise · HETLIOZ · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LEVORPHANOL TARTRATE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PADCEV · PANZYGA · PAXLOVID · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Senza · Soliris · Spritam · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TREXIMET · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · WAINUA · Wakix · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
294
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Diamond is a mixed practice specialist, with above-average Medicare volume (top 1% in NJ), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Diamond experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Diamond performed 34,745.1 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Diamond receive payments from pharmaceutical companies?
Yes. Dr. Diamond received a total of $101,111 from 103 companies across 1,272 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Diamond's costs compare to other neurologists in Morristown?
Dr. Diamond's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Diamond) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Morristown
Browse neurologists in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology